Navigation Links
ThromboGenics NV Announces Business Update and Half Year Results 2009
Date:8/27/2009

30/06/2009 30/06/2008 Unaudited consolidated statement of financial position In '000 Euro - According to IFRS ASSETS: Property plant and equipment 960 934 Intangible Assets 7,756 - Goodwill 2,586 2,586 Fixed Assets: 11,302 3,520 Trade and other receivables 2,442 32,236 Investments 5,721 6,684 Cash and cash equivalents 46,866 33,614 Current Assets 55,029 72,534 Pension 73 39 Long-term Assets 73 39 Total Assets 66,404 76,093 EQUITY AND LIABILITIES Share capital 113,997 111,086 Share premium 15,907 15,733 Accumulated translation differences 39 13 Other reserves (20,235) (21,199) Retained earnings (48,622) (38,026) Equity attributable to equity holders of the parent 61,086 67,607 Minority interests - - Total Equity 61,086 67,607 Trade payables 4,246 7,380 Other short-term liabilities 1,072 1,106 Short-term liabilities 5,318 8,486 Total Equity and Liabilities
'/>"/>
SOURCE ThromboGenics NV
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. ThromboGenics NV: Business Update
2. ThromboGenics Announces Business Update and 2008 Full Year Results
3. ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis
4. ThromboGenics N.V.: Business Update
5. ThromboGenics Announces Half Year Results 2008
6. ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
7. ThromboGenics Announces Private Investors Acquire 8% Stake in the Company
8. ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody
9. ThromboGenics N.V. - Business Update
10. ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
11. ThromboGenics Announces 2007 Full Year Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014 Earlier this month, a ... partnership with the U.S. Air Force on the performance ... indicated that this type of fuel made from mustard ... be important to America’s Eco friendly future. In fact, ... mandate to become independent of foreign oil over the ...
(Date:8/28/2014)... Whitehouse Laboratories is excited to announce ... PTI Inspection Systems that will enable it ... art leak testing method development and validation programs using ... As part of this agreement, Whitehouse Labs has taken ... Instrument developed and manufactured by PTI. The HVLD ...
(Date:8/27/2014)... , Aug. 27, 2014 Rhythm, a biopharmaceutical ... genetic deficiencies that result in metabolic disorders, announced today ... S-1 with the U.S. Securities and Exchange Commission (SEC) ... of its common stock. The number of shares to ... have not yet been determined. Citigroup and ...
(Date:8/27/2014)... 2014   MSC , a healthcare performance improvement ... the appointment of Mary Beth Loesch to ... of experience preparing companies for rapid growth and market ... President of Corporate Development and Healthcare. In that role, ... as well as corporate strategy and marketing. Previously, Loesch ...
Breaking Biology Technology:Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 2Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 3Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 4Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 5Whitehouse Labs Renews Partnership with PTI Inspection Systems 2Whitehouse Labs Renews Partnership with PTI Inspection Systems 3Rhythm Files Registration Statement for Proposed Initial Public Offering 2MSC names Mary Beth Loesch President and CEO 2
... to determine whether therapy after childbirth for women with von ... Willebrand disease is needed and for how long, ... is providing,a $1.2 million grant to fund a first-of-its kind, ... determining optimal prophylaxis,treatment for postpartum women with von Willebrand disease ...
... Mass., Aug. 18 Logical Therapeutics, Inc., ... medicines that treat,diseases associated with poorly controlled ... Phase 1b randomized controlled multi-dose,safety and pharmacokinetics ... The study, which was conducted from December, ...
... Global Pharmacology Space and Drug Target Knowledge Databases ... Related to Nuclear Receptors and ... leading provider of,knowledge management solutions that accelerate life sciences ... knowledge,databases. The new offerings include knowledge databases for the ...
Cached Biology Technology:Video: CSL Behring Provides $1.2M Grant for World's First Study of Postpartum Women with VWD, Common Bleeding Disorder 2Video: CSL Behring Provides $1.2M Grant for World's First Study of Postpartum Women with VWD, Common Bleeding Disorder 3Video: CSL Behring Provides $1.2M Grant for World's First Study of Postpartum Women with VWD, Common Bleeding Disorder 4Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug 2Aureus Pharma Releases New Unified Knowledge Database 2
(Date:8/29/2014)... surprising discoveries about the body,s initial responses to ... team found that specialized cells in the intestine ... invasion and are the source of gut inflammation ... , Though aimed at the presence of ... that provides a barrier to protect the body ...
(Date:8/29/2014)... Scientists at the Barshop Institute for Longevity and Aging ... UT Health Science Center at San Antonio, have found ... longest-lived rodent, the naked mole rat. , They ... mole rats protects and alters the activity of the ... , The factor also protects proteasome function in human, ...
(Date:8/29/2014)... MISSOULA Until recently, little has been known about ... An international team of scientists, one of whom is ... breakthrough by showing that genes controlling the development of ... for rabbit domestication., The study was published Aug. 28 ... genetic questions. It is online at http://www.sciencemag.org/ ., ...
Breaking Biology News(10 mins):The early cost of HIV 2Factor in naked mole rat's cells enhances protein integrity 2New research reveals how wild rabbits were genetically transformed into tame rabbits 2New research reveals how wild rabbits were genetically transformed into tame rabbits 3
... Kenji Shimada have received a four-year, $1.3 million grant ... tools for cryosurgery, which is the destruction of undesired ... At present, minimally invasive cryosurgery, such as ... the shape of long hypodermic needles with a cooling ...
... international group of anthropologists offers a new theory about the ... impact it had. Published the week of Dec. 7 ... , the study, co-authored by Gayle Fritz, Ph.D., professor of ... Louis, and colleagues*, suggests that maize was passed from group ...
... of Alabama at Birmingham (UAB) Center for Metabolic Bone ... Distinguished Service to Clinical Pathology from the American Society ... a professor in the UAB Department of Pathology, is ... clinical pathology training. McDonald helped author the current highest ...
Cached Biology News:Carnegie Mellon researchers receive grant 2The impact of the diffusion of maize to the Southwestern United States 2UAB bone center director wins distinguished service award from clinical pathology society 2
6B9...
Request Info...
Taq DNA Polymerase (T. aquaticus), 250 units. For PCR and other procedures requiring DNA polymerase activity at elevated temperatures. Category: Nucleotides & Enzymes & Biochemicals, Modifying Enzyme...
... 5 units/µL ,• High specific activity and ... an 'A' overhang ,• Processes ... very high activity in primer extension and ... quality of the enzyme, each lot has ...
Biology Products: